Compare EVAX & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVAX | RKDA |
|---|---|---|
| Founded | 2008 | 2002 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 1.1M |
| IPO Year | 2020 | 2015 |
| Metric | EVAX | RKDA |
|---|---|---|
| Price | $3.10 | $0.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.67 | N/A |
| AVG Volume (30 Days) | ★ 215.2K | 144.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,858,000.00 |
| Revenue This Year | N/A | $61.67 |
| Revenue Next Year | $328.20 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.77 | $0.38 |
| 52 Week High | $12.15 | $6.71 |
| Indicator | EVAX | RKDA |
|---|---|---|
| Relative Strength Index (RSI) | 49.43 | 36.71 |
| Support Level | $2.91 | $0.38 |
| Resistance Level | $3.62 | $0.55 |
| Average True Range (ATR) | 0.19 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 33.85 | 9.09 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.